Do you want to read an article? Please log in or register.
Radiological follow-up in patients with resected pulmonary carcinoids: Should we reduce radiation exposure?
Lung, Respiratory and Thoracic Cancer
Related content
ESMO 2024
Genitourinary Cancer
ARANOTE: Adding darolutamide to ADT significantly reduced the risk of radiological progression in patients with mHSPC
Breast Cancer
Breast conserving surgery with intraoperative electron beam radiation therapy for low-risk breast cancer: Five-year follow-up of 306 patients
Int J Cancer
de Jonge C, Schipper RJ, Walstra CJEF, Van Riet YE, Verrijssen AE, Voogd AC, van der Sangen MJC, Theuws J, Degreef E, Gielens MPM, Bloemen JG, van den Berg HA, Nieuwenhuijzen GAP
doi: 10.1002/ijc.35033
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Tasoudis P, Loufopoulos G, Manaki V, Doerr M, Agala CB, Long JM, Haithcock BE
doi: 10.1016/j.lungcan.2024.107929
Lung, Respiratory and Thoracic Cancer
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
J Thorac Oncol
Marinelli D, Nuccio A, Di Federico A, Ambrosi F, Bertoglio P, Faccioli E, Ferrara R, Ferro A, Giusti R, Guerrera F, Mammana M, Pittaro A, Sepulcri M, Viscardi G, Gallina FT
doi: 10.1016/j.jtho.2024.09.1443
Multiple Myeloma (MM)
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial
Lancet Haematol
Mina R, Mylin AK, Yokoyama H, Magen H, Alsdorf W, Minnema MC, Shune L, Isufi I, Harrison SJ, Shah UA, Schecter JM, Vogel M, Lendvai N, Gries KS, Katz EG, Slaughter A, Lonardi C, Gilbert J, Li Q, Deraedt W, Filho OC, Patel N, Florendo E, Karlin L, Weisel K
doi: 10.1016/S2352-3026(24)00320-X
Gastrointestinal Cancer
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
JAMA Oncol
Stoop TF, Sugawara T, Oba A, Feld IM, van Roessel S, van Veldhuisen E, Wu YHA, Nishino J, Ali M, Alseidi A, Sauvanet A, Mirabella A, Sa Cunha A, Kokkola A, Groot Koerkamp B, Pietrasz D, Kleive D, Butturini G, Malleo G, van Laarhoven HWM, Frigerio I, Dembinski J, He J, Gagnière J, Kleeff J, Ramia JM, Roberts KJ, Labori KJ, Marino MV, Falconi M, B Mortensen M, Lesurtel M, Bonds M, Chatzizacharias N, Strobel O, Turrini O, Griffin O, Franklin O, Pfeiffer P, Schulick RD, Salvia R, de Wilde RF, Dokmak S, Rodriguez Franco S, Augustinus S, Burgdorf SK, Crippa S, Hackert T, Tarvainen T, Burns WR, Messersmith W, Wilmink JW, Burkhart RA, Del Chiaro M, Besselink MG, Scientific Committee of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) and International Collaboration on Advanced Pancreatic Cancer
doi: 10.1001/jamaoncol.2024.5917
APCCC 2024
Genitourinary Cancer
STAMPEDE: Treatment intensification with ARPI significantly reduces the risk of fracture in patients with mHSPC
ELCC 2024
Lung, Respiratory and Thoracic Cancer
LBA2. CheckMate 77T: Improved efficacy with perioperative nivolumab in patients with resectable NSCLC
Lymphoma
Can the radiation dose be safely reduced in the treatment of nk/T cell lymphoma?
Leuk Lymphoma
Zhang X, Chai Y, Lib C D W, Zhao P, Zhang H, Wang P
doi: 10.1080/10428194.2024.2370433